APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Immunoglobulin For Intramuscular Injection (IMIG)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Outlook and Growth Opportunities 2026

23 December 2025199 pages

Choose your research edition.

Industry ResearchHuman Immunoglobulin For Intramuscular Injection (IMIG) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Human Immunoglobulin For Intramuscular Injection (IMIG) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Immunoglobulin For Intramuscular Injection (IMIG) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Immunoglobulin For Intramuscular Injection (IMIG) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Human Immunoglobulin For Intramuscular Injection (IMIG) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Human Immunoglobulin For Intramuscular Injection (IMIG) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Immunoglobulin For Intramuscular Injection (IMIG) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Immunoglobulin For Intramuscular Injection (IMIG) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Human Immunoglobulin For Intramuscular Injection (IMIG) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Human Immunoglobulin For Intramuscular Injection (IMIG) market include Takeda, Tiantan Biological, CSL Behring, Grifols, Pfizer, Hualan Biological, Henjiu, Octapharma and Kedrion Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Immunoglobulin For Intramuscular Injection (IMIG) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Immunoglobulin For Intramuscular Injection (IMIG) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Immunoglobulin For Intramuscular Injection (IMIG) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Immunoglobulin For Intramuscular Injection (IMIG) market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Immunoglobulin For Intramuscular Injection (IMIG) Segment by Company

Takeda

Tiantan Biological

CSL Behring

Grifols

Pfizer

Hualan Biological

Henjiu

Octapharma

Kedrion Biopharma

Human Immunoglobulin For Intramuscular Injection (IMIG) Segment by Type

Children

Adult

Human Immunoglobulin For Intramuscular Injection (IMIG) Segment by Application

Disease Prevention

Diagnosis

Treatment

Other

Human Immunoglobulin For Intramuscular Injection (IMIG) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Human Immunoglobulin For Intramuscular Injection (IMIG) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Human Immunoglobulin For Intramuscular Injection (IMIG) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Human Immunoglobulin For Intramuscular Injection (IMIG) significant trends, drivers, influence factors in global and regions.

6. To analyze Human Immunoglobulin For Intramuscular Injection (IMIG) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Immunoglobulin For Intramuscular Injection (IMIG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Immunoglobulin For Intramuscular Injection (IMIG) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Immunoglobulin For Intramuscular Injection (IMIG).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Immunoglobulin For Intramuscular Injection (IMIG) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Immunoglobulin For Intramuscular Injection (IMIG) industry.

Chapter 3: Detailed analysis of Human Immunoglobulin For Intramuscular Injection (IMIG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Human Immunoglobulin For Intramuscular Injection (IMIG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Human Immunoglobulin For Intramuscular Injection (IMIG) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Trends Table 2. Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Drivers Table 3. Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Opportunities and Challenges Table 4. Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Restraints Table 5. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Share by Company (2021-2026) Table 7. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Company (k units) & (2021-2026) Table 8. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume Share by Company (2021-2026) Table 9. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price (USD/unit) of Company (2021-2026) Table 10. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Key Company Manufacturing Base & Headquarters Table 12. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Company, Product Type & Application Table 13. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Immunoglobulin For Intramuscular Injection (IMIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Children Table 18. Significant Companies of Adult Table 19. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Type (2021-2026) & (k units) Table 21. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Type (2027-2032) & (k units) Table 22. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume Share by Type (2021-2026) Table 23. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume Share by Type (2027-2032) Table 24. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type (2021-2026) Table 28. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Disease Prevention Table 30. Significant Companies of Diagnosis Table 31. Significant Companies of Treatment Table 32. Significant Companies of Other Table 33. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Application (2021-2026) & (k units) Table 35. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Application (2027-2032) & (k units) Table 36. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume Share by Application (2021-2026) Table 37. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume Share by Application (2027-2032) Table 38. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application (2021-2026) Table 42. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application (2027-2032) Table 43. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region (2021-2026) & (k units) Table 45. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Region (2021-2026) Table 46. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region (2027-2032) & (k units) Table 47. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Region (2027-2032) Table 48. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Region (2021-2026) Table 51. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Region (2027-2032) Table 53. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026) & (k units) Table 58. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country (2021-2026) Table 59. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2027-2032) & (k units) Table 60. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Country (2027-2032) Table 61. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Market Share by Country (2021-2026) Table 63. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Market Share by Country (2027-2032) Table 65. Takeda Company Information Table 66. Takeda Business Overview Table 67. Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 69. Takeda Recent Development Table 70. Tiantan Biological Company Information Table 71. Tiantan Biological Business Overview Table 72. Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 74. Tiantan Biological Recent Development Table 75. CSL Behring Company Information Table 76. CSL Behring Business Overview Table 77. CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 79. CSL Behring Recent Development Table 80. Grifols Company Information Table 81. Grifols Business Overview Table 82. Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 84. Grifols Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 89. Pfizer Recent Development Table 90. Hualan Biological Company Information Table 91. Hualan Biological Business Overview Table 92. Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 94. Hualan Biological Recent Development Table 95. Henjiu Company Information Table 96. Henjiu Business Overview Table 97. Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 99. Henjiu Recent Development Table 100. Octapharma Company Information Table 101. Octapharma Business Overview Table 102. Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 104. Octapharma Recent Development Table 105. Kedrion Biopharma Company Information Table 106. Kedrion Biopharma Business Overview Table 107. Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio Table 109. Kedrion Biopharma Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Human Immunoglobulin For Intramuscular Injection (IMIG) Distributors List Table 113. Human Immunoglobulin For Intramuscular Injection (IMIG) Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Human Immunoglobulin For Intramuscular Injection (IMIG) Product Image Figure 2. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales (2021-2032) & (k units) Figure 5. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Children Image Figure 10. Adult Image Figure 11. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume Share by Type (2021-2032) Figure 14. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type (2021-2032) Figure 17. Disease Prevention Image Figure 18. Diagnosis Image Figure 19. Treatment Image Figure 20. Other Image Figure 21. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume Share by Application (2021-2032) Figure 24. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application (2021-2032) Figure 27. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Human Immunoglobulin For Intramuscular Injection (IMIG) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Children
  • Adult
Applications
  • Disease Prevention
  • Diagnosis
  • Treatment
  • Other
Companies covered
  • Takeda
  • Tiantan Biological
  • CSL Behring
  • Grifols
  • Pfizer
  • Hualan Biological
  • Henjiu
  • Octapharma
  • Kedrion Biopharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (2021-2032)
  4. 1.2.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume (2021-2032)
  5. 1.2.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Human Immunoglobulin For Intramuscular Injection (IMIG) Market Dynamics
  1. 2.1 Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Trends
  2. 2.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Drivers
  3. 2.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Opportunities and Challenges
  4. 2.4 Human Immunoglobulin For Intramuscular Injection (IMIG) Industry Restraints
3 Human Immunoglobulin For Intramuscular Injection (IMIG) Market by Company
  1. 3.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Company Revenue Ranking in 2025
  2. 3.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Company (2021-2026)
  3. 3.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Company (2021-2026)
  4. 3.4 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Company (2021-2026)
  5. 3.5 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Company Ranking (2024-2026)
  6. 3.6 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Company Manufacturing Base and Headquarters
  7. 3.7 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Company Product Type and Application
  8. 3.8 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Human Immunoglobulin For Intramuscular Injection (IMIG) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Human Immunoglobulin For Intramuscular Injection (IMIG) Market by Type
  1. 4.1 Human Immunoglobulin For Intramuscular Injection (IMIG) Type Introduction
  2. 4.1.1 Children
  3. 4.1.2 Adult
  4. 4.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Type
  5. 4.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Type
  9. 4.3.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type (2021-2032)
5 Human Immunoglobulin For Intramuscular Injection (IMIG) Market by Application
  1. 5.1 Human Immunoglobulin For Intramuscular Injection (IMIG) Application Introduction
  2. 5.1.1 Disease Prevention
  3. 5.1.2 Diagnosis
  4. 5.1.3 Treatment
  5. 5.1.4 Other
  6. 5.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Application
  7. 5.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Application
  11. 5.3.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application (2021-2032)
6 Human Immunoglobulin For Intramuscular Injection (IMIG) Regional Sales and Value Analysis
  1. 6.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region (2021-2032)
  3. 6.2.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region: 2021-2026
  4. 6.2.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Region (2027-2032)
  5. 6.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Region (2027-2032)
  9. 6.5 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (2021-2032)
  12. 6.6.2 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (2021-2032)
  15. 6.7.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (2021-2032)
  21. 6.9.2 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Country, 2025 VS 2032
7 Human Immunoglobulin For Intramuscular Injection (IMIG) Country-level Sales and Value Analysis
  1. 7.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2032)
  4. 7.3.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2021-2026)
  5. 7.3.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales by Country (2027-2032)
  6. 7.4 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Tiantan Biological
  8. 8.2.1 Tiantan Biological Company Information
  9. 8.2.2 Tiantan Biological Business Overview
  10. 8.2.3 Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  12. 8.2.5 Tiantan Biological Recent Developments
  13. 8.3 CSL Behring
  14. 8.3.1 CSL Behring Company Information
  15. 8.3.2 CSL Behring Business Overview
  16. 8.3.3 CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  18. 8.3.5 CSL Behring Recent Developments
  19. 8.4 Grifols
  20. 8.4.1 Grifols Company Information
  21. 8.4.2 Grifols Business Overview
  22. 8.4.3 Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  24. 8.4.5 Grifols Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Hualan Biological
  32. 8.6.1 Hualan Biological Company Information
  33. 8.6.2 Hualan Biological Business Overview
  34. 8.6.3 Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  36. 8.6.5 Hualan Biological Recent Developments
  37. 8.7 Henjiu
  38. 8.7.1 Henjiu Company Information
  39. 8.7.2 Henjiu Business Overview
  40. 8.7.3 Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  42. 8.7.5 Henjiu Recent Developments
  43. 8.8 Octapharma
  44. 8.8.1 Octapharma Company Information
  45. 8.8.2 Octapharma Business Overview
  46. 8.8.3 Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  48. 8.8.5 Octapharma Recent Developments
  49. 8.9 Kedrion Biopharma
  50. 8.9.1 Kedrion Biopharma Company Information
  51. 8.9.2 Kedrion Biopharma Business Overview
  52. 8.9.3 Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product Portfolio
  54. 8.9.5 Kedrion Biopharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Immunoglobulin For Intramuscular Injection (IMIG) Value Chain Analysis
  2. 9.1.1 Human Immunoglobulin For Intramuscular Injection (IMIG) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Mode & Process
  6. 9.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Distributors
  9. 9.2.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst